SquamousCellCarcinomaofSkin near Palm Harbor, FL

Care Philosophy: Dr Guilherme Rabinowits is a Senior Member in the Department of Head and Neck-Endocrine Oncology. Dr Rabinowits received his MD degree from Fundacao Tecnico-Educacional Souza Marques, Rio de Janeiro, Brazil. He completed an Internal Medicine residency at Lahey Clinic and Medical Center, Burlington, Massachusetts, followed by a Hematology/Medical Oncology Fellowship at the University of Louisville, Kentucky, where he also served as Chief Fellow. He then joined Dana-Farber Cancer Institute/Harvard Medical School, Boston, Massachusetts, as a Head and Neck Medical Oncologist until his move to Miami. Dr Rabinowits joins us from the Miami Cancer Institute, Department of Hematology/Medical Oncology.

Care Philosophy: Dr Eroglu is a medical oncologist in the Department of Cutaneous Oncology at Moffitt Cancer Center and an assistant professor in the Department of Oncologic Sciences at the University of South Florida Morsani College of Medicine. Her clinical focus is on treating patients with advanced melanoma and other skin cancers, including basal cell carcinoma and Merkel cell carcinoma, and participating in clinical trials.Dr Eroglu's research interests are translational and clinical research in targeted therapies and combination immunotherapeutics for melanoma and other skin cancers, along with development of personalized treatment strategies and biomarkers for patients with melanoma.

Biography: Dr. Robert Tawil, MD is a Dermatologist who practices in Tampa, FL. He is 71 years old and has been practicing for 43 years. Dr. Robert Tawil, MD is affiliated with HCA Florida South Tampa Hospital.

Care Philosophy: Ahmad Tarhini, MD, PhD is an internationally recognized physician and leading researcher in Melanoma, Skin Cancers and Immuno-Oncology. Dr Tarhini is a Tenured Senior Member in the Moffitt Cancer Center and Research Institute Departments of Cutaneous Oncology and Immunology. Dr Tarhini also serves as the Director of Cutaneous Clinical and Translational Research and leader of the Neoadjuvant and Adjuvant Translational Science Program. He is Professor of Oncologic Sciences at the University of South Florida Morsani College of Medicine. Dr Tarhini also serves as Chair, Scientific Committee, Oncology Research Information Exchange Network (ORIEN) and Chair, ORIEN ImmunoOncology Research Subcommittee.